Profiel
Emily Guthrie worked as a Management Consultant at The Boston Consulting Group, Inc. from 2019 to 2021.
Dr. Guthrie worked as a Research Lead at Patient Square Capital from 2023 to 2025.
Dr. Guthrie completed an undergraduate degree at Brown University in 2012.
Dr. Guthrie earned a doctorate from the University of California, Berkeley in 2019.
Eerdere bekende functies van Emily Guthrie
| Bedrijven | Functie | Einde |
|---|---|---|
Patient Square Capital
Patient Square Capital Investment ManagersFinance Patient Square invests in both private and public companies located in the United States. The firm targets companies operating in the fields of health care and technology sectors such as development-stage therapeutics, commercial-stage pharmaceuticals, medical devices, diagnostics & life science tools, health care providers and tech-enabled & other services. It provides financing for buyout transactions. | Hoofd Techniek/Wetenschap/O&O | 01-10-2025 |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Consultant / Adviseur | 01-04-2021 |
Opleiding van Emily Guthrie
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Patient Square Capital
Patient Square Capital Investment ManagersFinance Patient Square invests in both private and public companies located in the United States. The firm targets companies operating in the fields of health care and technology sectors such as development-stage therapeutics, commercial-stage pharmaceuticals, medical devices, diagnostics & life science tools, health care providers and tech-enabled & other services. It provides financing for buyout transactions. | Finance |
















